Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis: Preliminary results after one year
- 1 January 2005
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 40 (7) , 873-874
Abstract
(2005). Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis: Preliminary results after one year. Scandinavian Journal of Gastroenterology: Vol. 40, No. 7, pp. 873-874.Keywords
This publication has 4 references indexed in Scilit:
- Upper gastrointestinal toxicity of alendronateAmerican Journal of Gastroenterology, 2000
- Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: Preliminary results after 2 yearsGastroenterology, 1997
- Esophagitis Associated with the Use of AlendronateNew England Journal of Medicine, 1996
- Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodelingThe American Journal of Medicine, 1995